SPRC logo

SPRC
Scisparc Ltd

5,570
Mkt Cap
$6.52M
Volume
98,084.00
52W High
$37.59
52W Low
$1.75
PE Ratio
-0.10
SPRC Fundamentals
Price
$4.02
Prev Close
$3.98
Open
$4.08
50D MA
$3.83
Beta
0.74
Avg. Volume
13.07M
EPS (Annual)
-$22.65
P/B
0.25
Rev/Employee
$653,000.00
Loading...
Loading...
News
all
press releases
SciSparc And AutoMax Motors Scrap Proposed Merger
The decision was mutual, and the merger agreement is null, effective immediately, SciSparc said.
Stocktwits·19d ago
News Placeholder
More News
News Placeholder
SciSparc Stock Soared 61% Today – Here’s An Important Update
The company will establish a dedicated research team to integrate quantum computing algorithms into 3D protein modeling, aiming to create new intellectual property.
Stocktwits·1mo ago
News Placeholder
Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome
SciSparc secures FDA approval for Phase IIb clinical trial of SCI-110, targeting unmet needs in Tourette Syndrome, Global trial begins soon. read more...
Benzinga·1y ago
News Placeholder
Clearmind Medicine Files International Patent For Ibogaine Combination Therapy
Clearmind Medicine filed an international patent for a treatment that aims to enhance addiction treatment safety and efficacy. read more...
Benzinga·1y ago
News Placeholder
SciSparc and Clearmind Innovate in Mental Health Therapy
SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., a pharmaceutical company specializing in central nervous system disorders, has revealed...
TipRanks Financial Blog·1y ago
News Placeholder
SciSparc Initiates Groundbreaking Autism Therapy Trial
SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., a pharmaceutical firm focused on central nervous system disorders, has launched a clini...
TipRanks Financial Blog·1y ago
News Placeholder
Israeli Penny Stock Biotech SciSparc Outlicenses Its Cannabinoid Pain Therapy
SciSparc signs an exclusive license agreement with Polyrizon Ltd for its SCI-160 pain treatment program, with potential milestones of $3M in cash plus royalties. read more...
Benzinga·1y ago
News Placeholder
SciSparc Eyes $6M Deal for Pain Treatment License
SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., a clinical-stage pharmaceutical company, has announced a non-binding letter of intent t...
TipRanks Financial Blog·1y ago
News Placeholder
SciSparc Ltd. Faces Nasdaq Delisting Over Bid Price
SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., a biopharmaceutical firm focusing on central nervous system disorders, has been notifie...
TipRanks Financial Blog·1y ago
News Placeholder
SciSparc says Clearmind submits international patent application for depression
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago

Latest SPRC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.